A dose-ranging study of imeglimin in Japanese type 2 diabetic subjects
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Imeglimin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Poxel
- 30 Jun 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2017 Results published in a Poxel media release.
- 06 Jun 2017 Data will be presented at the European Association for the Study for Diabetes 53rd Annual Meeting 2017, according to a Poxel media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History